Acquired/developmental learning disorders, childhood peer relations, brain:behavior relations, ADHD, Autism Spectrum Disorders
Pediatric/child clinical psychology, learning disorders, developmental neuropsychology, ADHD, Adult ADHD, Autism Spectrum Disorders, Sports Psychology
Teaching/Supervision of Psychodynamic Psychotherapy
Psychoanalytic Psychotherapy; Object Relations Theory
Treatment issues in schizophrenia: economics of health care.
Tailoring treatments for individudal patients: integrating psychotherapy and psychopharmacology
Biomarkers for Psychosis in Velocardiofacial Syndrome (NIMH Grant)
Child Psychiatric Diagnosis & Treatment by Primary Care Providers
Child and Adolescent Psychiatry
Teaching Primary Care Providers
PTSD, Multicultural Issues; Children, Adolescents and Families; Psychology of Women; Child Psychiatry and Primary Care
Borderline personality disorder, addictions, neuroscience, psychotherapy
personality disorders, psychotherapy, addictions, biopsychosocial integration
Borderline personality disorder, addictions, psychotherapy
Integrative treatments for Psychiatric conditions as well as Breast Cancer.
Integrative Holistic Medicine
Treatment of mentall illness in cancer patients
Integrative treatment options for mental illness and cancer
The goal of Dr. Johnson’s research is to understand how opioids exert their effects by addressing clinical challenges that appear unrelated but are unified by an innovative theory. We propose a theory that unifies the nature of these disorders by assuming that each involves a dysregulation of the opioid system based on data suggesting that opioid dependence and fibromyalgia are associated with low opioid tone whereas autism is associated with high opioid tone. Our first challenge, therefore, is to create and validate a treatment for opioid dependence that corrects persistent hormonal changes after detoxification. Our second challenge is to treat fibromyalgia. Our third challenge is to assess whether autism is a disease of too-high opioid tone by blocking excess opioid stimulation to treat the symptoms. Opioid dependence, fibromyalgia, and autism are three disorders that cause much distress and disability but are difficult to treat. We test our theory by treating opioid dependence and fibromyalgia with low-dose naltrexone and autism with high-dose naltrexone. Our theory suggests a novel approach that could improve the quality of life of patients suffering from these debilitating disorders.
ADHD, PTSD and SLEEP DISORDERS
ADHD, Sleep Disorders and Psychodynamic Psychotherapy.
Epidemiology/pharmacotherapy of schizophrenia; Ego strength among inpatients & its relation to engagement in treatment; cardiovascular risk factors in patients with serious mental illness; changes in cognition in response to depression treatment
Biostatistical/epidemiologic principles and their application in evaluating the scientific literature; personality disorders
Management of treatment resistant depression/schizophrenia
Smoking and alcohol use disorders commonly occur together. People who drink alcohol are three times more likely to smoke, and smokers are four times more likely than the general population to be dependent on alcohol. When nicotine and alcohol dependence occur together, the health risks are increased, and the chances of quitting smoking and drinking are lower. The exact mechanism of co-occurring nicotine and alcohol dependence is not clearly understood. In everyday clinical practice, interventions used for smoking cessation are not combined with treatment of alcohol dependence. Our clinical research program is focused on developing new medications to treat alcohol and nicotine dependence simultaneously. Two investigational new drugs recently tested at our division decreased drinking and/or smoking severity and prevented cognitive problems associated with smoking and drinking. Our goal is to establish the safety and efficacy of these neuroprotective agents in different patient populations. Preventing cognitive decline is of great importance to inpatients with addiction. Development of new, neuroprotective medications may reduce harm associated with heavy smoking and alcohol use.
Dr. Miller's research has focused on the clinical implications of language, as well as contemporary clinical applications of psychoanalytic and psychodynamic theory. He is particularly interested in the work of Jacques Lacan. He is the author of Lacanian Psychotherapy: Theory and Practical Applications (Routledge, 2011).
Anxiety disorders, mood disorders, complex trauma effects, sexuality. Dr. Miller's treatment approach is informed by psychodynamic/psychoanalytic and existential-phenomenological theory.
Health psychology dependency health service utilization
Provide consulting service to groups/organizations/business partners through Upstate's Institute for Decision Excellence and Leadership
Coronary artery disease link to depression and mortality
Neuroscience of psychotherapy; psychosomatic medicine
Neuroscience; Jungian and depth psychotherapy; psychosomatic medicine
Cognitive Behavioral Therapy for depression and anxiety disorders.
One aspect of academic psychiatry and teaching is to cultivate medical students and residents and to steer them towards understanding and conducting clinical research. In the Department of Psychiatry, Dr. Schwartz and his colleagues James Megna, M.D., Adekola Alao, M.D., and others, have strong track records of involving students and residents in research. Students and residents routinely present posters at national meetings and have their work published in reputable journals. Students and residents learn how to write case histories, case series, create and conduct surveys, analyze datasets collected by faculty, and occasionally conduct prospective trials. We feel these fundamental research experiences are the gateway to launching careers in more in-depth and formal clinical research for our students and residents. Fortunately, these research experiences can be developed for a fraction of the cost of starting a new research project, but nevertheless funding for such experiences cannot be easily obtained from typical funding streams, such as the U.S. National Institutes of Health.
PLease note, not accepting new patients
My research focuses on the psychosocial issues that affect patients with diabetes and those at risk for diabetes. In my work, we are developing and testing effective and practical interventions for patients with diabetes, those at risk, and their partners, to help them achieve better physical health (e.g., control of blood sugar, weight) and quality of life. We are also seeking to understand how depression and anxiety may interfere with the health of diabetes patients.
Diabetes and depression Diabetes and marital quality Psychological predictors of surgical outcome
Health services delivery
Impact of health policy